These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19672785)

  • 1. Expressions of androgen receptor and its co-regulators in carcinoma ex pleomorphic adenoma of salivary gland.
    Nakajima Y; Kishimoto T; Nagai Y; Yamada M; Iida Y; Okamoto Y; Ishida Y; Nakatani Y; Ichinose M
    Pathology; 2009; 41(7):634-9. PubMed ID: 19672785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HER-2/neu gene amplification in carcinoma ex pleomorphic adenoma in relation to progression and prognosis: a chromogenic in-situ hybridization study.
    Hashimoto K; Yamamoto H; Shiratsuchi H; Nakashima T; Tamiya S; Nishiyama K; Higaki Y; Komune S; Tsuneyoshi M; Oda Y
    Histopathology; 2012 May; 60(6B):E131-42. PubMed ID: 22486195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical evaluation of androgen receptor, HER-2/neu, and p53 in benign pleomorphic adenomas.
    DeRoche TC; Hoschar AP; Hunt JL
    Arch Pathol Lab Med; 2008 Dec; 132(12):1907-11. PubMed ID: 19061288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual gain of HER2 and EGFR gene copy numbers impacts the prognosis of carcinoma ex pleomorphic adenoma.
    Nishijima T; Yamamoto H; Nakano T; Nakashima T; Taguchi K; Masuda M; Motoshita J; Komune S; Oda Y
    Hum Pathol; 2015 Nov; 46(11):1730-43. PubMed ID: 26345124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive (intracapsular) carcinoma ex pleomorphic adenoma: recognition of focal carcinoma by HER-2/neu and MIB1 immunohistochemistry.
    Di Palma S; Skálová A; Vanìèek T; Simpson RH; Stárek I; Leivo I
    Histopathology; 2005 Feb; 46(2):144-52. PubMed ID: 15693886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of expression of Plag1 in malignant transformation from pleomorphic adenoma to carcinoma ex pleomorphic adenoma.
    de Brito BS; Giovanelli N; Egal ES; Sánchez-Romero C; Nascimento JS; Martins AS; Tincani ÁJ; Del Negro A; Gondak RO; Almeida OP; Kowalski LP; Altemani A; Mariano FV
    Hum Pathol; 2016 Nov; 57():152-159. PubMed ID: 27473265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct copy number signatures between residual benign and transformed areas of carcinoma ex pleomorphic adenoma.
    Scarini JF; Sabino WL; de Lima-Souza RA; Egal ESA; Tincani AJ; Gondak R; Kowalski LP; Krepischi ACV; Altemani A; Mariano FV
    Sci Rep; 2024 Oct; 14(1):23645. PubMed ID: 39384827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Carcinoma ex pleomorphic adenoma of major salivary glands--a clinicopathologic review].
    Stodulski D; Rzepko R; Kowalska B; Stankiewicz C
    Otolaryngol Pol; 2007; 61(5):687-93. PubMed ID: 18552001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A low percentage of HER-2 amplification whereas indicates poor prognosis in salivary carcinoma ex pleomorphic adenoma: a study of 140 cases.
    Xia L; Hu Y; Li J; Gu T; Zhang C; Wang L; Tian Z
    J Oral Pathol Med; 2017 Mar; 46(3):167-174. PubMed ID: 27423271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of the Rb pathway in recurrent pleomorphic adenoma of the salivary glands.
    de Souza AA; Altemani A; Passador-Santos F; Turssi CP; de Araujo NS; de Araújo VC; Soares AB
    Virchows Arch; 2015 Sep; 467(3):295-301. PubMed ID: 26155914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoma ex pleomorphic adenoma, with particular emphasis on early lesions.
    Di Palma S
    Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S68-76. PubMed ID: 23821206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLAG1 alteration in carcinoma ex pleomorphic adenoma: immunohistochemical and fluorescence in situ hybridization studies of 22 cases.
    Bahrami A; Dalton JD; Shivakumar B; Krane JF
    Head Neck Pathol; 2012 Sep; 6(3):328-35. PubMed ID: 22485045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a subset of tumor suppressor gene for copy number and epigenitic changes in pleomorphic adenoma and carcinoma ex-pleomorphic adenoma carcinogenesis.
    Mariano FV; Egal ES; Pramio D; Fidalgo F; Sara É; Costa AF; de Oliveira Gondak R; Coletta RD; de Almeida OP; Kowalski LP; Victorino Krepischi AC; Altemani A
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Sep; 122(3):322-31. PubMed ID: 27544395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoma ex pleomorphic adenoma of the salivary gland: an immunohistochemical study.
    Matsubayashi S; Yoshihara T
    Eur Arch Otorhinolaryngol; 2007 Jul; 264(7):789-95. PubMed ID: 17310348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoma ex pleomorphic adenoma of the salivary glands: distinct clinicopathologic features and immunoprofiles between subgroups according to cellular differentiation.
    Kim JW; Kwon GY; Roh JL; Choi SH; Nam SY; Kim SY; Cho KJ
    J Korean Med Sci; 2011 Oct; 26(10):1277-85. PubMed ID: 22022178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of differentially expressed microRNAs as potential biomarkers for carcinoma ex pleomorphic adenoma.
    Kim H; Eun S; Jeong WJ; Ahn SH; Bae YJ; Lee JS; Kim H
    Sci Rep; 2022 Aug; 12(1):13383. PubMed ID: 35927424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter hypermethylation may contribute to E‑cadherin repression in the human salivary carcinoma ex pleomorphic adenoma.
    Xia L; Hu Y; Gu T; Wang L; Tian Z
    Int J Oncol; 2018 Feb; 52(2):496-504. PubMed ID: 29207084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-erbB-2 oncoprotein expression and amplification in pleomorphic adenoma and carcinoma ex pleomorphic adenoma: relationship to prognosis.
    Müller S; Vigneswaran N; Gansler T; Gramlich T; DeRose PB; Cohen C
    Mod Pathol; 1994 Aug; 7(6):628-32. PubMed ID: 7991521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular Proliferation Index between Carcinoma Ex-Pleomorphic Adenoma and Pleomorphic Adenoma.
    Mariano FV; Costa AF; Gondak RO; Martins AS; Del Negro A; Tincani ÁJ; Altemani A; de Almeida OP; Kowalski LP
    Braz Dent J; 2015; 26(4):416-21. PubMed ID: 26312983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoma ex-pleomorphic adenoma derived from recurrent pleomorphic adenoma shows important difference by array CGH compared to recurrent pleomorphic adenoma without malignant transformation.
    Mariano FV; Giovanetti K; Saccomani LF; Del Negro A; Kowalski LP; Krepischi AC; Altemani A
    Braz J Otorhinolaryngol; 2016; 82(6):687-694. PubMed ID: 26971045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.